DYADIC INTERNATIONAL INC Operating Lease, Expense
DYADIC INTERNATIONAL INC (DYAI) reported Operating Lease, Expense of $119.54 thousand for the 12-month period ending 2025-12-31, per its 10-K filed 2026-03-25.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:OperatingLeaseExpense · last filed 2026-03-25
- DYADIC INTERNATIONAL INC operating lease, expense for the quarter ending 2023-12-31 was $26.66K.
- DYADIC INTERNATIONAL INC operating lease, expense for the quarter ending 2023-09-30 was $15.00K.
- DYADIC INTERNATIONAL INC operating lease, expense for fiscal 2025 was $119.54K, a 11.94% increase from fiscal 2024.
- DYADIC INTERNATIONAL INC operating lease, expense for fiscal 2024 was $106.78K, a 49.02% increase from fiscal 2023.
- DYADIC INTERNATIONAL INC operating lease, expense for fiscal 2023 was $71.66K, a 23.54% increase from fiscal 2022.
- DYADIC INTERNATIONAL INC operating lease, expense for fiscal 2022 was $58.00K.
| Period end | Operating Lease, Expense 3 month | Operating Lease, Expense 6 month | Operating Lease, Expense 9 month | Operating Lease, Expense 12 month | Operating Lease, Expense 12 month as first filed |
|---|---|---|---|---|---|
| 2025-12-31 | $119.54K 10-K · filed 2026-03-25 | ||||
| 2024-12-31 | $106.78K 10-K · filed 2026-03-25 | ||||
| 2023-12-31 | $26.66K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-26 | $41.66K derived: sum of 2 quarters · filed 2025-03-26 | $71.66K 10-K · filed 2025-03-26 | $72.00K 10-K · filed 2024-03-28 | |
| 2023-09-30 | $15.00K 10-Q · filed 2023-11-08 | $45.00K 10-Q · filed 2023-11-08 | |||
| 2022-12-31 | $58.00K 10-K · filed 2024-03-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| BioCardia, Inc. (BCDA) | United States | $0.016B | |
| Passage BIO, Inc. (PASG) | United States | $0.015B | -0.43 |
| Pluri Inc. (PLUR) | $0.014B | ||
| INTENSITY THERAPEUTICS, INC. (INTS) | United States | $0.013B | -1.08 |
| BRAINSTORM CELL THERAPEUTICS INC. (BCLI) | United States | $0.013B | -1.05 |
| Jasper Therapeutics, Inc. (JSPR) | United States | $0.020B | -0.37 |
| IN8BIO, INC. (INAB) | United States | $0.012B | -0.76 |
| Estrella Immunopharma, Inc. (ESLA) | United States | $0.020B | |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |
| TScan Therapeutics, Inc. (TCRX) | United States | $0.008B | -1.23 |